Cahill Wealth Management, LLC Viking Therapeutics, Inc. Transaction History
Cahill Wealth Management, LLC
- $172 Million
- Q1 2024
A detailed history of Cahill Wealth Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Cahill Wealth Management, LLC holds 9,846 shares of VKTX stock, worth $533,160. This represents 0.47% of its overall portfolio holdings.
Number of Shares
9,846Holding current value
$533,160% of portfolio
0.47%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
426Shares Held
63.2MCall Options Held
7.39MPut Options Held
5.13M-
Black Rock Inc. New York, NY8.27MShares$448 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.79MShares$422 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.59MShares$194 Million3.55% of portfolio
-
State Street Corp Boston, MA3.33MShares$180 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$126 Million0.02% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.15B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...